We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$4.25B
AUM Growth
+$350M
Cap. Flow
+$86.2M
Cap. Flow %
2.03%
Top 10 Hldgs %
36.46%
Holding
3,532
New
211
Increased
1,529
Reduced
874
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 16.32%
2 Healthcare 9.45%
3 Financials 6.67%
4 Communication Services 4.66%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONL
3351
Orion Office REIT
ONL
$160M
$24 ﹤0.01%
6
RGTI icon
3352
Rigetti Computing
RGTI
$5.99B
$23 ﹤0.01%
30
URNM icon
3353
Sprott Uranium Miners ETF
URNM
$1.98B
0
NKLA
3354
DELISTED
Nikola Corporation Common Stock
NKLA
$23 ﹤0.01%
5
KBE icon
3355
State Street SPDR S&P Bank ETF
KBE
$1.66B
0
SRS icon
3356
ProShares UltraShort Real Estate
SRS
$15.4M
$22 ﹤0.01%
+1
New +$51
AKO.B icon
3357
Embotelladora Andina Series B
AKO.B
$4.95B
$20 ﹤0.01%
1
ECF
3358
Ellsworth Growth & Income Fund
ECF
$172M
$19 ﹤0.01%
2
OABI icon
3359
OmniAb
OABI
$447M
$17 ﹤0.01%
4
WHWK
3360
Whitehawk Therapeutics
WHWK
$271M
$16 ﹤0.01%
8
HLX icon
3361
Helix Energy Solutions
HLX
$1.41B
$11 ﹤0.01%
1
AVTX icon
3362
Avalo Therapeutics
AVTX
$983M
$10 ﹤0.01%
1
DCTH icon
3363
Delcath Systems
DCTH
$524M
$9 ﹤0.01%
1
OCUL icon
3364
Ocular Therapeutix
OCUL
$2.02B
$9 ﹤0.01%
+1
New +$8
EHAB
3365
DELISTED
Enhabit
EHAB
$8 ﹤0.01%
1
MVST icon
3366
Microvast
MVST
$302M
$7 ﹤0.01%
30
KALA icon
3367
KALA BIO
KALA
$14.5M
0
ALZN icon
3368
Alzamend Neuro
ALZN
$6.56M
0
ABVEW
3369
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$5 ﹤0.01%
+300
New +$11
AVAL icon
3370
Grupo Aval
AVAL
$6.01B
$4 ﹤0.01%
2
-252
-99% -$528
CLOV icon
3371
Clover Health Investments
CLOV
$2.51B
-1
Closed -$2
IMUX icon
3372
Immunic
IMUX
$195M
0
AKTS
3373
DELISTED
Akoustis Technologies Inc
AKTS
$3 ﹤0.01%
30
CCO icon
3374
Clear Channel Outdoor Holdings
CCO
$1.23B
$2 ﹤0.01%
1
VIRX
3375
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2 ﹤0.01%
8

Similar funds

Parallel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Parallel Advisors held 3,532 positions worth $4.25B, up 9% from $3.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q3 2024 filing shows 211 new, 1,529 increased, 874 reduced and 128 closed positions. Its largest new stake was iShares Investment Grade Systematic Bond ETF: 445,057 shares worth $20.7M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $38.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q3 2024 buy was iShares Investment Grade Systematic Bond ETF: 445,057 shares worth $20.7M.
  • Parallel Advisors added most to iShares S&P 500 Growth ETF in Q3 2024, an estimated $35.1M increase.
  • Parallel Advisors's biggest Q3 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $38.2M.
  • Parallel Advisors fully exited Encore Wire Corp in Q3 2024, selling an estimated $281K.
  • Parallel Advisors's ten largest holdings make up 36% of its $4.25B portfolio in Q3 2024.
  • Parallel Advisors opened 211 new positions and closed 128 in Q3 2024.
  • Parallel Advisors's portfolio value rose 9% quarter-over-quarter to $4.25B.

Based on Parallel Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.